258 related articles for article (PubMed ID: 27310438)
1. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
Straňák Z; Saliba E; Kosma P; Posfay-Barbe K; Yunis K; Farstad T; Unnebrink K; van Wyk J; Wegzyn C; Notario G; Kalus S; Campbell FJ
PLoS One; 2016; 11(6):e0157446. PubMed ID: 27310438
[TBL] [Abstract][Full Text] [Related]
2. Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.
Maksić H; Heljić S; Skokić F; Šumanović-Glamuzina D; Milošević V; Zlatanović A; Gerard N
Bosn J Basic Med Sci; 2018 Aug; 18(3):279-288. PubMed ID: 29750895
[TBL] [Abstract][Full Text] [Related]
3. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
Simões EAF; Madhi SA; Muller WJ; Atanasova V; Bosheva M; Cabañas F; Baca Cots M; Domachowske JB; Garcia-Garcia ML; Grantina I; Nguyen KA; Zar HJ; Berglind A; Cummings C; Griffin MP; Takas T; Yuan Y; Wählby Hamrén U; Leach A; Villafana T
Lancet Child Adolesc Health; 2023 Mar; 7(3):180-189. PubMed ID: 36634694
[TBL] [Abstract][Full Text] [Related]
5. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
Madhi SA; Kuwanda L; Cutland C; Klugman KP
J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Respiratory Syncytial Virus Infections in Moderate/Late Premature Infants in Turkey: A Prospective Multicenter Epidemiological Study.
Ozkan H; Celebi S; Koksal N; Hacımustafaoğlu M; Koc E; Tezer H; Cetinkaya M; Cebeci B; Erdeve O; Ozdemir H;
Am J Perinatol; 2021 Dec; 38(14):1540-1546. PubMed ID: 32659789
[TBL] [Abstract][Full Text] [Related]
7. The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil.
Arruda E; Jones MH; Escremim de Paula F; Chong D; Bugarin G; Notario G; Matsuno AK; Pitrez PM; Vo P; Suzuki C; Rosario Filho N; Stein RT
Pediatr Infect Dis J; 2014 Oct; 33(10):997-1003. PubMed ID: 25361184
[TBL] [Abstract][Full Text] [Related]
8. Respiratory Syncytial Virus Associated Hospitalizations in Infants of 33 to 42 Weeks' Gestation: Does Gestational Age Matter?
Resch B; Wörner C; Özdemir S; Hubner M; Puchas C; Urlesberger B
Klin Padiatr; 2019 Jul; 231(4):206-211. PubMed ID: 30887492
[TBL] [Abstract][Full Text] [Related]
9. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
Stockman LJ; Curns AT; Anderson LJ; Fischer-Langley G
Pediatr Infect Dis J; 2012 Jan; 31(1):5-9. PubMed ID: 21817948
[TBL] [Abstract][Full Text] [Related]
11. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
[TBL] [Abstract][Full Text] [Related]
12. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.
Carbonell-Estrany X; Quero J;
Pediatr Infect Dis J; 2001 Sep; 20(9):874-9. PubMed ID: 11734767
[TBL] [Abstract][Full Text] [Related]
14. Lower respiratory tract illness and RSV prophylaxis in very premature infants.
Lacaze-Masmonteil T; Truffert P; Pinquier D; Daoud P; Goldfarb G; Vicaut E; Fauroux B
Arch Dis Child; 2004 Jun; 89(6):562-7. PubMed ID: 15155404
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
Zachariah P; Ruttenber M; Simões EA
J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.
Ambrose CS; Anderson EJ; Simões EA; Wu X; Elhefni H; Park CL; Sifakis F; Groothuis JR
Pediatr Infect Dis J; 2014 Jun; 33(6):576-82. PubMed ID: 24622396
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for acute respiratory syncytial virus infection of lower respiratory tract in hospitalized infants].
Zhang X; Liu L; Shi P; Jiang G; Jia P; Wang C; Wang L; Qian L
Zhonghua Er Ke Za Zhi; 2014 May; 52(5):373-7. PubMed ID: 24969937
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis.
Cetinkaya M; Oral TK; Karatekin S; Cebeci B; Babayigit A; Yesil Y
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1629-1634. PubMed ID: 28391538
[TBL] [Abstract][Full Text] [Related]
19. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
[TBL] [Abstract][Full Text] [Related]
20. Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
Gantenberg JR; van Aalst R; Zimmerman N; Limone B; Chaves SS; La Via WV; Nelson CB; Rizzo C; Savitz DA; Zullo AR
J Infect Dis; 2022 Aug; 226(Suppl 2):S164-S174. PubMed ID: 35968869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
